Background: Lymphocytic-plasmacytic enteritis is the common form of idiopathic
has been suggested that dysfunction of the mucosal immune system with loss of tolerance to luminal antigens plays an important role in its pathogenesis. 1 The etiology of human IBD also remains to be established. 2 In humans, plasma amino acid analysis is used to provide a metabolomic assessment of health status. Moreover, disturbances of metabolic homeostasis are involved in the pathogenesis of metabolic diseases, chronic inflammatory disorders, and cancers. [3] [4] [5] Specific disturbances in amino acid metabolism characterize the pathophysiological stage of IBD, and therefore the plasma amino acid profile represents a novel, noninvasive, diagnostic, and staging marker for human IBD. 6, 7 In veterinary medicine, the plasma amino acid profile is altered in dogs with mammary gland tumors, critical illness, or superficial necrolytic dermatitis. [8] [9] [10] Therefore, plasma amino acid concentrations might provide useful biomarkers in dogs with various disorders. There are alterations in serum amino acid concentrations in dogs with protein-losing enteropathy (PLE). 11 Therefore, the aim of the present study was to characterize the plasma amino acid profile of dogs with IBD.
| MATERIALS AND METHODS

| Animals and plasma samples
Heparinized plasma samples were obtained from 10 dogs with IBD.
Dogs referred to our veterinary hospital between August 2012 and
September 2013 for evaluation of chronic gastrointestinal tract disorders were recruited for this study. A diagnosis of IBD was made on the basis of clinical signs (vomiting, diarrhea, and weight loss) of at least 3 weeks' duration, the exclusion of other causes of gastrointestinal manifestations, and the identification of lymphoplasmacytic inflammation on the histopathologic review of duodenal biopsy samples.
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The exclusion criterion was evidence of other causes of gastrointestinal manifestations, including metabolic disease, infection, parasitic disease, and other causes of hypoalbuminemia, including hepatic and renal disease. Such evidence was provided by performing a complete blood count, a serum biochemistry profile including preprandial total bile acids, fecal examination, urinalysis including urinary protein-tocreatinine ratio, and abdominal radiography and ultrasonography. Foodresponsive diarrhea was ruled out by the lack of complete remission of clinical signs after 2 weeks of feeding an elimination diet, 15 Animal Veterinary Association (WSAVA). 12 All the dogs diagnosed with IBD were also scored using the canine chronic enteropathy clinical activity index (CCECAI) for assessment of the clinical severity of their disease. 16 The total CCECAI score was classified as grade 1 (score 0-3), 
| Plasma amino acids analysis
Blood samples for amino acid analysis were collected in heparinized tubes after at least 8 hours of fasting to minimize the influence of diet on circulating amino acids. Heparinized blood was immediately centrifuged and the plasma separated. Then, the plasma total protein (TP), albumin (ALB), and C-reactive protein (CRP) concentrations were measured by dry chemistry (Dry-Chem 7000 Z, Fujifilm Medical, Tokyo, Japan). Plasma samples for amino acid analysis were stored at −80 C until analysis, then briefly thawed, mixed with same volume of 5% (w/v) trichloroacetic acid, and centrifuged for 15 minutes at 9000g at 4 C to remove proteins. The supernatant was collected and filtered through a .45-μm syringe filter (Millipore, Bedford, Massachusetts).
Plasma amino acids were separated by cation-exchange chromatography and identified spectrophotometrically after reaction with ninhydrin reagent. Twenty-one basic amino acids (alanine, arginine, asparagine, citrulline, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine, and valine) were assayed using an automated amino acid analyzer (L-8900, Hitachi, Tokyo, Japan).
| Statistical analysis
The data were analyzed using JMP Pro 12 software (SAS Institute Inc, Cary, North Carolina). Their normality was assessed using the Shapiro- respectively. Four of the 10 IBD dogs were hypoalbuminemia (ALB <2.6 g/dL) and 6 were normoalbuminemia (ALB ≥2.6 g/dL). Plasma ALB concentration was significantly lower (P = .02) and plasma CRP concentration was significantly higher (P < .001) in dogs with IBD.
There was also a significant difference in body mass (P < .001)
between IBD dogs and control dogs. In contrast, the age and sex distribution were not significantly different (P > .06) between the 2 groups.
| Plasma amino acid concentrations in dogs with IBD
In dogs with IBD, the plasma concentrations of 4 amino acids (methionine, proline, serine, and tryptophan) were significantly lower than in control dogs (Table 1) . There was a significant negative correlation between plasma serine concentration and total CCECAI scores in dogs with IBD (Figure 1 ), but none of the plasma amino acid concentrations of dogs with IBD showed correlations with plasma CRP or overall WSAVA scores. In addition, there were no significant differences in any of the plasma amino acid concentrations between the 4 hypoalbuminemic IBD dogs and the 6 normoalbuminemic dogs after Bonferroni correction (P > .04).
| DISCUSSION
In the present study, we aimed to identify disturbances in amino acid metabolism in dogs with IBD. Significantly lower plasma methionine, proline, serine, and tryptophan concentrations were found in dogs with IBD, and plasma serine concentration was negatively correlated with CCECAI score. However, we did not find any differences in plasma amino acid concentrations between IBD dogs with hypoalbuminemia or normoalbuminemia, although a previous study of dogs with PLE reported that only serum tryptophan concentration was significantly decreased in PLE dogs compared to healthy dogs.
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In this study, we used the post-column ninhydrin method for plasma amino acid analysis. This method is thought to be a more quantitative and reproducible analytical method than pre-column derivatization followed by high-performance liquid chromatography, and less likely to be affected by the nature of matrix containing the biogenic substance, such as serum or plasma. However, 1 major disadvantage is that it has a lower sensitivity than the pre-column method. Nevertheless, on balance, the post-column ninhydrin method appears suitable for the analysis of amino acids concentrations in plasma.
In human IBD, plasma histidine and tryptophan concentrations are significantly lower than normal and show negative correlations with disease activity indexes. 6 Serum tryptophan concentrations are significantly lower in dogs with PLE than in healthy dogs. Serum tryptophan concentration also correlates with serum ALB concentration in dogs with PLE, but not with clinical disease stage (CCECAI scores).
Whereas in our study, the concentrations of 4 amino acids including tryptophan and serine were significantly lower than those of control dogs, and only plasma serine concentration showed a negative correlation with CCECAI scores. Thus, plasma serine concentration might represent a novel marker in dogs with IBD.
Serine act on protease-activated receptor (PAR)-2, which is expressed widely, but particularly in the intestine. 17 Intestinal PAR-2 and fecal serine protease activity are higher in dogs with IBD and might contribute to intestinal cytokine expression. 18 In murine and human cell lines, serine proteases produced by infectious Enterobacteriaceae induce inflammatory responses through PAR-2. 19, 20 Moreover, the high fecal serine protease activity reflects dysbiosis of the intestinal microbiome in human IBD patients. 21 Thus, fecal serine proteases might originate in intestinal bacteria under inflammatory conditions. Intestinal dysbiosis, with overrepresentation of fecal Enterobacteriaceae, occurs in dogs with IBD. 22 Therefore, it is possible that intestinal serine is consumed by pathogenic bacteria, and lower plasma serine concentrations might be the result of serine protease synthesis by the abnormal intestinal microbiome in dogs with IBD.
Tryptophan is the least prevalent essential amino acid in mammals. 23 Tryptophan supplementation ameliorates clinical signs, improves feed conversion ratio, ameliorates histologic signs of colonic inflammation, and reduces gut permeability and the expression of several pro-inflammatory cytokines in animal models of dextran sodium sulfate-induced colitis. 23, 24 Recently, interest in amino acids, including tryptophan, has been focused on the relationship between intestinal inflammation and their therapeutic potential in IBD. [25] [26] [27] Therefore, oral supplementation with tryptophan might represent a novel therapeutic strategy for dogs with IBD, especially in IBD dogs with PLE. Because, similar to the result of the present study, serum tryptophan concentration is low in dogs with PLE. 11 One of the mechanisms whereby tryptophan supplementation could be therapeutically effective is through inhibition of reactive oxygen species, such as superoxide. 24 Tryptophan T A B L E 1 Plasma amino acid concentrations in dogs with inflammatory bowel disease (IBD) and healthy control dogs 
